The Center for Biodesign and in-vitro Diagnostics (CBD) has been established as one of the Centers of THSTI with the mission to undertake innovation in medical technologies for affordable health care in India.
This center aims to transform the field by creating a novel medical technology enterprise in India for affordable health care through a “Biodesign process”, which essentially utilises inputs from clinical-care settings to innovate or improve existing designs.
The Centre has developed the technologies on clones for recombinant tissue transglutaminase; innovative diagnostic tool for measuring blood sugar level coupled with mobile phone technology; rapid, simple and sensitive test modules for HIV, HBV and HCV; rapid diagnosis of TB, MDR-TB & XDR-TB and recombinant human antibody library for rapid screening of antigens.
The technology developed on clone of recombinant human tissue transglutaminase has been successfully transferred to J. Mitra Pvt. Ltd. this year for development of tests for celiac disease.
An MOU was signed between THSTI and University of Turku for creation of an Indo Finnish Diagnostic Research Center.